Advanced gastric cancer
Conditions
Interventions
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with gastric cancer diagnosed pathologically; 2. Patients with TNM stage ?; 3. Patients with age = 18 years old, regardless of gender; 4. Patients with Karnofsky score = 60; 5. Patients who have been or will receive systematic Chinese medicine treatment (oral treatment of syndrome differentiation and treatment Decoction at the TCM oncologist's office); 6. Patients who voluntarily accept the study and sign the informed consent form can cooperate with the follow-up once every 2 months, about 6 times, and cooperate to improve the current treatment measures and relevant information.
Exclusion criteria
Exclusion criteria: 1. Patients with two or more primary malignant tumors; 2. Patients with serious non neoplastic diseases and dysfunction, active cerebrovascular diseases, uncontrolled infection and metabolic diseases, neuropsychiatric diseases, cognitive dysfunction and other important organs such as heart, lung, liver, kidney, etc; 3. Patients can not or refuse to take oral medicine; 4. The patients whose expected survival time is less than 3 months; 5. Other situations that the researcher thinks are not suitable to participate in this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival;progression-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Response Evaluation Criteria in Solid Tumors;Karnofsky Performance Scale;EORTC QLQ-C30 (V3.0) and QLQ-STO22 score;MD Anderson Symptom Inventory; | — |
Countries
China
Contacts
Public ContactHou Li
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Outcome results
None listed